Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atomoxetine Effects on Stress and Amphetamine Response
NCT00607568Phase 2Completed
- Sponsor
- Yale University
- Start
- Jun 2006
- Primary completion
- Aug 2007
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of atomoxetine in stress, sponsored by Yale University. Primary endpoints: Physiological responses to stress and d-amphetamine at 6 hours, Subjective responses to stress and d-amphetamine at 6 hours and 1 more. Started Jun 2006; status: completed.
02
Drugs
atomoxetine
03
Conditions
stress
Beyond the preview
Go deeper on NCT00607568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00607568.